drugset / Trial / NCT02681796

Epidural Analgesia Use in Pancreatic Resections

NCT02681796

Phase 1 Completed 23 enrolled Washington University School of Medicine
RandomizedParallel-groupSingle-blindSupportive care

Summary

The rationale for this study is to investigate the benefits of epidural analgesia in pancreatic resections in a prospective, single blind, randomized control trial. This study will evaluate both short and long-term outcomes related to epidural analgesia, providing a longitudinal and comprehensive perspective to the advantages and disadvantages of this technique. The investigators hypothesize that the use of epidural analgesia reduces a patient's consumption of morphine or morphine-equivalent in the post-operative period following pancreatic resections.

Timeline

Start
2016-06-07
Primary completion
2020-02-07
Completion
2020-02-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 0.125 % Other